Financials

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
5140
OCS
Oculis Holding AG - Ordinary shares
7.90 USD-2.35%+8.97%-16.05%-62.96%0 USD
5153
ANL
Adlai Nortye Ltd - American Depositary Shares
10.58 USD0.00%-3.56%-34.04%+565.41%0 USD
5439
CELG-RT
Bristol-Myers Squibb Company Celegne Contingent Value Rights
0.1245 USD+6.14%+16.90%+13.80%+262.97%0 USD
6255
ADAP
Adaptimmune Therapeutics plc - American Depositary Shares
0.05 USD0.00%0.00%-61.54%-28.57%0 USD

Frequently asked questions about Novo-Nordisk A/S

What is the Novo-Nordisk A/S stock price today?

The current price of Novo-Nordisk A/S (NVO) is 39.03. Over the past 24 hours, the stock has changed by -1.04%. Follow the NVO chart for real-time price dynamics.

What is the stock ticker of Novo-Nordisk A/S?

Novo-Nordisk A/S trades under the ticker NVO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Novo-Nordisk A/S stock going up?

NVO has changed by +0.98% over the last week, +0.57% over the last month, and -26.02% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Novo-Nordisk A/S?

Novo-Nordisk A/S currently has a market capitalization of 0. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Does Novo-Nordisk A/S release financial reports?

Yes. You can track Novo-Nordisk A/S financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

How many employees does Novo-Nordisk A/S have?

As of the latest available data, Novo-Nordisk A/S has 69.5 K employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Novo-Nordisk A/S stock?

You can buy Novo-Nordisk A/S (NVO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Novo-Nordisk A/S stock?

Investing in Novo-Nordisk A/S requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NVO chart and related analysis on metatrader.com as part of your research.

Novo Nordisk A/S

Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily obesity and diabetes medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s. Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares. Novo is a full member of the European Federation of Pharmaceutical Industries and Associations. The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten. Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe.

News